Implementation of AEROECLIPSE® II BAN™ Nebulizer based therapy has the potential to reduce costs associated with staff acquisition of nosocomial influenza.
Implementation of AEROECLIPSE® II BAN™ Nebulizer based therapy has the potential to reduce costs associated with staff acquisition of nosocomial influenza.
